We’re thrilled to see Dr Foong share his expertise on this global stage at #PACTRIMS. Over 50% of people with #MS are aged over 50, and his research is helping to shape their care. Dive into his team's latest papers here:
🔗 jnnp.bmj.com/content/earl...
🔗 journals.sagepub.com/doi/full/10....

A big thank you to ANZAN, co-authors and all respondents!

3/ Conclusion: Neurologists are concerned about climate change and its impact on patients, but most feel uncomfortable raising it in routine clinical care. Our findings support the need for more mitigation strategies for our patients. #Climatechange #Neurology #BrainHealth #MS #Neurosky #Medsky

2/ Reported impacts:
🔥 Heat worsening MS, epilepsy, Parkinson’s
🌫️ Air pollution linked to stroke & dementia
🌪️ Natural disasters disrupting access to care

1/ Most neurologists agree:
✔️ Climate change is real
✔️ It’s already affecting patients
But many feel underprepared to address it in practice.

Conclusion
Worse baseline cognitive performance and lack of a practice effect predicted future cognitive decline in RRMS. Thanks to all participants, collaborators and supervisors!

📊 Results
• Stability: PST scores were stable over time at a population level
• Latent Classes: Four trajectories emerged - those with worst baseline cognitive performance and lack of a practice effect were at greater risk of future decline

I would be a little bit hesitant re the results - short follow up (1 year), industry sponsored by the makers of said fumarate, inadequate matching...

yes, it's bizarre it doesnt have greater coverage. Saddening.